Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. If you are wondering whether Avantor's current share price ...

Life sciences company Avantor (NYSE:AVTR) reported Q4 CY2025 results , but sales fell by 1.4% year on year to $1.66 billion. Its non-GAAP profit of $0.22 per share was in line with analysts’ consensus ...

Business: Avantor is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The company's segments include ...

Avantor is a turnaround play in life sciences distribution and manufacturing, trading at a historically low valuation after a 50% stock decline. New management is executing a Revival program targeting ...

Avantor Inc. (NYSE: AVTR) stock is trading lower on Wednesday after the company reported fourth-quarter adjusted earnings of 22 cents, in line with the consensus. • Avantor shares are approaching ...

Recent commentary highlights that Avantor’s core business has underperformed over the past two years, with organic revenue disappointing and sales expected to fall further as it contends with a ...

Transaction value based on SEC Form 4 reported price ($11.35); post-transaction value was $3,083,653.12 based on trade-date close price. Avantor provides a broad portfolio of high-purity materials, ...

Avantor, Inc. (NYSE:AVTR) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. The company’s Q1 2025 results exhibited disciplined execution as well as a continued focus on ...

Avantor AVTR recently entered into a strategic partnership with BlueWhale Bio to accelerate innovation in CAR-T cell therapy manufacturing. The collaboration merges Avantor’s bioprocessing expertise ...

RADNOR, Pa., Nov. 10, 2025 /PRNewswire/ -- Avantor, Inc. (AVTR) (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced ...